Argentatin B Inhibits Proliferation of Prostate and Colon Cancer Cells by Inducing Cell Senescence
Open accessThe DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.
Abstract
Argentatin B has been shown to inhibit the growth of colon HCT-15, and prostate PC-3 cancer cells. However, the mechanism by which argentatin B inhibits cell proliferation is still unknown. We aimed to investigate the mechanism by which argentatin B inhibits cell proliferation. The cell cycle was studied by flow cytometry. Apoptosis was evaluated by Annexin-V-Fluos, and Hoechst 33342 dye staining. Cell senescence was evaluated by proliferation tests, and staining for SA-β-galactosidase. Senescence-related proteins (PCNA, p21, and p27) were analyzed by Western blotting. Potential toxicity of argentatin B was evaluated in CD-1 mice. Its effect on tumor growth was tested in a HCT-15 and PC-3 xenograft model. Argentatin B induced an increment of cells in sub G1, but did not produce apoptosis. Proliferation of both cell lines was inhibited by argentatin B. Forty-three percent HCT-15, and 66% PC-3 cells showed positive SA-β-galactosidase staining. The expression of PCNA was decreased, p21 expression was increased in both cell lines, but p27 expression increased only in PC-3 cells after treatment. Administration of argentatin B to healthy mice did not produce treatment-associated pathologies. However, it restricted the growth of HCT-15 and PC-3 tumors. These results indicate that treatment with argentatin B induces cell senescence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“have been reported to reduce tumour growth in murine cancer models with less toxicity than cisplatin [18, 21].”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The triterpenes are biologically active compounds with proven in vitro antiproliferative activity against CRC cell lines [18].”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“argentatins also show antitumor activity in several cell lines derived from different types of cancer [18, 19, 20]”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687 · cited 1×
“In 2012, approximately 42% of compounds in clinical trials as antitumor agents were natural products, compounds derived from secondary metabolites, or designed from a natural product pharmacophore [1].”
Backgroundp21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118 · cited 1×
“Senescence-associated signaling pathways activate important cell cycle negative r gulators, like p21 which is a strong inhibitor f y lin-dependent kinases [23], and p27 which is a negative regulator of G1 rogression [24].”
BackgroundIf not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725 · cited 1×
“Interestingly, commonly used chemotherapeutic drugs, such as cisplatin, doxorubicin, etoposide and other topoisomerase inhibitors are capable of inducing senescence of cancer cells when they used in very low concentrations [29,30].”
BackgroundHallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502 · cited 1×
“Interestingly, commonly used chemotherapeutic drugs, such as cisplatin, doxorubicin, etoposide and other topoisomerase inhibitors are capable of inducing senescence of cancer cells when they used in very low concentrations [29,30].”
BackgroundGrösch, S., Tegeder, I., Niederberger, E., Bräutigam, L., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0299fje · Cited by 501 · cited 2×
“celecoxib [26], consistently induce an increment of p21 expression in different colon cancer-derived cell lines.”
BackgroundMolecular effects of paclitaxel: Myths and reality (a critical review)
Blagosklonny, M. V., & Fojo, T. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991008)83:2<255::aid-ijc18>3.0.co;2-x · Cited by 366
Reyes-Zurita, F. J., Rufino-Palomares, E. E., Lupiáñez, J. A., & Cascante, M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.07.033 · Cited by 197 · cited 2×
“So e of these secondary etabolites have sho n i portant anti-infla atory and antitu or activities [3].”
BackgroundResveratrol Induces Premature Senescence in Lung Cancer Cells via ROS-Mediated DNA Damage
Luo, H., Yang, A., Schulte, B. A., Wargovich, M. J., & Wang, G. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060065 · Cited by 176 · cited 2×
“Similarly, administration of 20–50 μM resveratrol has been reported to produce senescence in lung cancer cells after 10 to 12 days incubation [21].”
Background
Research works printed but not linked: 2
- Ortega, 1970, Determinación de las estructuras de las argentatinas A, B y C del guayule, Rev. Latinoam. Quim., 1, 24
- Calzada, 1995, Effect of tetracyclic triterpenes (argentatins A, B and D) on the estradiol receptor of hormone-dependent tumours of human breast, Med. Sci. Res., 23, 815
Cited by
Xu, J., Chen, Q., Tian, K., Liang, R., Chen, T., Gong, A., Mathy, N. W., Yu, T., & Chen, X. (2020) · Oncology Reports · doi:10.3892/or.2020.7665 · Cited by 116
Liu, B., Peng, Z., Zhang, H., Zhang, N., Liu, Z., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02284-z · Cited by 105
“For example, guanylate cyclase inhibitor LY83583 [287], sodium val-proate (a known HDAC inhibitor) [288], Argentatin B [289], 1,25(OH)2D3 [290], adapalene [291] and carvacrol [292] all enhance p21 expression, inhibit CDK and cyclins activity, and induce cellular senescence.”
Dehghanizadeh, M., Mendoza Moreno, P., Sproul, E., Bayat, H., Quinn, J. C., & Brewer, C. E. (2021) · Industrial Crops and Products · doi:10.1016/j.indcrop.2021.113410 · Cited by 51
Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review
Fakhri, S., Moradi, S. Z., Ash-Rafzadeh, A., & Bishayee, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105961 · Cited by 39
Gypenoside L Inhibits Proliferation of Liver and Esophageal Cancer Cells by Inducing Senescence
Ma, J., Hu, X., Liao, C., Xiao, H., Zhu, Q., Li, Y., Liu, Z., Tao, A., He, Z., Xu, C., et al. (2019) · Molecules · doi:10.3390/molecules24061054 · Cited by 36
“Argentatin B, a cycloartane-type triterpene, derived from Parthenium argentatum Gray (guayule), induces senescence in prostate and colon cancer cells [26].”
BackgroundMadasu, C., Xu, Y.-M., Wijeratne, E. M. K., Liu, M. X., Molnár, I., & Gunatilaka, A. A. L. (2022) · Medicinal Chemistry Research · doi:10.1007/s00044-021-02835-1 · Cited by 30
Tavarez-Santamaría, Z., Jacobo-Herrera, N. J., Rocha-Zavaleta, L., Zentella-Dehesa, A., Couder-García, B. D. C., & Martínez-Vázquez, M. (2020) · Molecules · doi:10.3390/molecules25081780 · Cited by 22
“We have also reported both the cytotoxic activity against various human cancer cell lines and the antitumor effect in a xenograft prostate model of Argentatin B (AB) from doses as high as 500 mg/kg [19].”
BackgroundMethodInfluentialSelf-citationRomero-Benavides, J. C., Bailon-Moscoso, N., Parra-Delgado, H., Ramirez, M. I., Villacis, J., Cabrera, H., Gonzalez-Arevalo, G., Cueva, R., Zentella-Dehesa, A., Ratovitski, E. A., et al. (2018) · Medicinal Chemistry Research · doi:10.1007/s00044-017-2106-4 · Cited by 17
“Argentatin B (1) has been shown to inhibit cell growth in several cancer cell lines (Parra-Delgado et al. 2005) and to reduce tumor growth in vivo (Alcántara-Flores et al. 2015).”
BackgroundSelf-citationArgentatin Content in Guayule Leaves (Parthenium argentatum A. Gray)
García-Martínez, M. M., Gallego, B., Latorre, G., Carrión, M. E., De la Cruz-Morcillo, M. Á., Zalacain, A., & Carmona, M. (2023) · Plants · doi:10.3390/plants12102021 · Cited by 8
Argentatins obtained from guayule as potential therapeutic agents in lung cancer
Silva‐Nolasco, A. M., Martín-Nieves, V., de la Cruz-Morcillo, M. Á., & Carmona, M. (2025) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.121474 · Cited by 6
Agronomic practices impact argentatin content in guayule (Parthenium argentatum A. Gray)
Gallego, B., García-Martínez, M. M., Sánchez‐Gómez, R., Latorre, G., de Mendoza, J. H., Zalacaın, A., & Carmona, M. (2023) · Industrial Crops and Products · doi:10.1016/j.indcrop.2023.116402 · Cited by 7
Molecular Diversity from Arid‐Land Plants: Valorization of Terpenes and Biotransformation Products
Bailén, M., Martínez-Díaz, R. A., Hoffmann, J. J., & González‐Coloma, A. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.201900663 · Cited by 6
Sánchez‐Olivares, P., Silva‐Nolasco, A. M., de la Cruz‐Morcillo, M. A., García‐Martínez, M. M., Pinedo‐Serrano, A., Carmona, M., & Galán‐Moya, E. M. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70294 · Cited by 5
Microbial transformation of some triterpenoids of Guayule resin by Chaetomium sp.
Inácio, M. C., Zhong, W., Xu, Y.-M., Wijeratne, E. M. K., Madasu, C., Molnár, I., & Gunatilaka, A. A. L. (2023) · Phytochemistry Letters · doi:10.1016/j.phytol.2023.05.001 · Cited by 5
New strategies to analyze argentatins A and B in guayule (Parthenium argentatum, A. Gray)
Gallego, B., García-Martínez, M. M., Latorre, G., Carrión, M. E., Hurtado de Mendoza, J., Carmona, M., & Zalacain, A. (2023) · Talanta · doi:10.1016/j.talanta.2023.124856 · Cited by 4
Hernández-Flandes, A., Hernández‐Ortega, S., Ramírez‐Ápan, T., Rocha‐Zavaleta, L., Silva-Jiménez, N., & Martínez‐Vázquez, M. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202301346 · Cited by 4
Self-citationSilva‐Nolasco, A. M., de la Cruz-Morcillo, M. Á., García-Martínez, M. M., Latorre, G., Carrión, M. E., Zalacaın, A., Martínez‐Vázquez, M., & Carmona, M. (2026) · Phytochemistry Reviews · doi:10.1007/s11101-026-10264-4
“…that was used as a positive control in some of the assays, the concentrations at which the argentatins exhibited a cytotoxic effect were very low (Alca´ntara-Flores et al. 2015; Flores-Rosete and Martı´nez-Va´zquez 2008; Herna´ndez-Flandes et al. 2024; Parra-Delgado et al. 2005a, b;…”
InfluentialSelf-citation
Metadata
- Authors
- Alcántara-Flores, E., Brechú-Franco, A., García-López, P., Rocha-Zavaleta, L., López-Marure, R., & Martínez-Vázquez, M.
- Affiliations
- Universidad Nacional Autónoma de México (MX)
- Instituto Nacional de Cancerología, Subdirección de Investigación Básica, Tlalpan, C.P. 14080, México D.F., Mexico
- Instituto de Investigaciones Biomédicas, Departamento de Biología Molecular y Biotecnología, Universidad Nacional Autónoma de México, Circuito Escolar s/n, Coyoacán, C.P. 04510, México, D.F., Mexico
- Instituto Nacional de Cardiología “Ignacio Chávez”, Departamento de Biología Celular, Juan Badiano No. 1, Colonia Sección 16, Tlalpan, C.P. 14080, México D.F., Mexico
- Instituto de Química, Departamento de Productos Naturales, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Coyoacán, C.P. 04510, México D.F., Mexico
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2015-11-27
- Volume
- 20
- Issue
- 12
- Pages
- 21125-21137
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6332290
- OpenAlex
- W2174443992
- Cited by
- 17
- References
- 32
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2017: 1
- FWCI
- 0.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Consejo Nacional de Ciencia y Tecnología (152650)
- Directorate for Biological Sciences
- Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, prostate cancer, colon cancer, cell proliferation inhibition, PC-3 cells, HCT-15 cells, SA-β-galactosidase, p21, p27, PCNA, sub-G1 cell cycle arrest, xenograft tumor growth, cytotoxicity
- MeSH terms
- Animals, Cell Cycle, Colonic Neoplasms, Flow Cytometry, Humans, Male, Mice, Nude, Prostatic Neoplasms, Triterpenes, Tumor Cells, Cultured, Blotting, Western, Cellular Senescence, Apoptosis, Xenograft Model Antitumor Assays, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.